PRNewsWire
17 Sept 2026, 02:51 UTC · 5h ago
Verdict
Headline leans bearish. We score CAPR −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
An advisory committee voted 9-3 that available evidence does not support the efficacy of deramiocel for treating DMD-associated cardiomyopathy.
Priced inreported by Medscape on July 30, 2026
So whatThis failure of the lead product candidate likely forces a complete write-down of the asset's projected NPV in FY2027 models.
More negative than 99% of claims this week
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The FDA claimed Capricor's statistical analysis plan changes were not agreed upon prior to BLA submission and considered the resulting analyses post-hoc and exploratory.
Priced inFDA briefing documents released July 27, 2026
So whatAllegations of data integrity issues typically lead to a permanent valuation discount regardless of future trial results.
More negative than 96% of claims this week
Capricor securities holders have until September 28, 2026, to seek appointment as lead plaintiff in a class action lawsuit alleging securities fraud.
Newannounces deadline in press release dated Sep 16
So whatWhile the stock already fell 100% cumulatively (64% then 36%), a certified class action creates a potential cash settlement liability for the balance sheet.
More negative than 73% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit following a massive stock price collapse and FDA concerns over the efficacy and data integrity of its lead product candidate.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
5h ago
—
CAPR hasn't traded since this ran. Last close $8.56 (Sep 16); the reaction starts at the next open.
CAPR chart →
